Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Capital Leases (2020 - 2021)

Updated

Analysis

Celularity (CELU) Capital Leases (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.19 Bn 1,108.77 Bn 19.71 Bn
2 Johnson & Johnson 634.59 Bn 554.45 Bn 17.30 Bn
3 AbbVie 499.62 Bn 472.73 Bn 12.70 Bn
4 Merck 354.90 Bn 309.28 Bn 12.21 Bn
5 Novartis Ag 300.00 Bn 263.99 Bn 11.24 Bn
6 Astrazeneca 263.32 Bn 237.01 Bn 12.86 Bn
7 Amgen 238.09 Bn 193.49 Bn 7.24 Bn
8 Gilead Sciences 193.99 Bn 168.19 Bn 6.22 Bn
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn
10 Celularity 28.36 Mn 21.11 Mn 3.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 28.09 Mn
Sep 30, 2021 28.02 Mn
Dec 31, 2020 27.63 Mn
API Access

Celularity Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CELU&period=max&api_key=YOUR_API_KEY